CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 1 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q4 2021 | $4,000 | -71.4% | 1,112 | -67.0% | 0.00% | – |
| Q3 2021 | $14,000 | -62.2% | 3,370 | -46.8% | 0.00% | – |
| Q2 2021 | $37,000 | -70.6% | 6,331 | -38.9% | 0.00% | – |
| Q1 2021 | $126,000 | +96.9% | 10,364 | +137.2% | 0.00% | – |
| Q4 2020 | $64,000 | +64.1% | 4,370 | +29.7% | 0.00% | – |
| Q3 2020 | $39,000 | – | 3,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 0 | $0 | 0.00% |